Company Email Format Management

Arecor Therapeutics

Biotechnology Research Little Chesterford, United Kingdom 34 employees

Employees: 34
Contacts: 2
Emails: 2
Phones: 1

arecor.com LinkedIn Crunchbase

Arecor Therapeutics Overview

Headquarters: Little Chesterford, United Kingdom
Phone Number: Available in AeroLeads
Website: arecor.com
Industry: Biotechnology Research
Employees: 34
Founded: 2007
Funding: 7.4M
Company Email: Available in AeroLeads
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Diabetes Ready-to-Administer (RTA) formats Ready-to-Use (RTU) formats Liquid products with superior stability Lyo-to-liquid switch IV to SQ High Concentration mAbs Differentiated Biosimilars Vaccine Stability Freedom-to-Operate (FTO) formulations

About Arecor Therapeutics

Arecor Therapeutics plc is a globally focused biopharmaceutical company transforming patient care by bringing innovative medicines to market through the enhancement of existing therapeutic products. By applying our innovative proprietary formulation technology platform, Arestat™, we are developing an internal portfolio of proprietary products in diabetes and other indications, as well as working with leading pharmaceutical and biotechnology companies to deliver enhanced formulations of their therapeutic products. The Arestat™ platform is supported by an extensive patent portfolio.

Arecor Therapeutics Contact Details

People in AeroLeads: 4
With contact data: 2
Email contacts: 2; 50.0% coverage
Phone contacts: 1; 25.0% coverage

Arecor Therapeutics Org Chart

Sample employees and titles

Name	Title	Location	Contact
David Ellam	Life Sciences CFO	United Kingdom	Email
Jeremy Morgan	President, Kyowa Kirin International		View
Vijay Pillai	Cmc Expert – Biopharma - Sterile Drug		View
David Gerring	Chief Development Officer (Cdo)	Greater Cambridge Area, United Kingdom	Email Phone